List of works - Angelo Ferrante

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

scientific article published on 23 October 2009

Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

scientific article published on March 2003

Cognitive impairment in Behçet's disease patients without overt neurological involvement

scientific article

Detection of anti-myeloperoxidase antibodies in the serum of patients with type 1 diabetes mellitus

scientific article published on 01 July 1996

Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels

scientific article published on 01 June 1999

Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.

scientific article

Glucocorticoid excess and COVID-19 disease

scientific article published on 06 October 2020

Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells

scientific article published on 01 August 2000

Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease

scientific article

IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells

scientific article published on 01 March 1998

Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis.

scientific article published in December 2009

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs

scientific article published on 27 October 2009

Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation

scientific article published on 05 August 2010

Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.

scientific article

Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.

scientific article

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

scientific article (publication date: March 2003)

Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome

scientific article published on 06 March 2014

The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis

scientific article published on 03 May 2014

The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome.

scientific article published on 04 February 2014

List of works by Angelo Ferrante

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis

Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.

Cognitive impairment in Behçet's disease patients without overt neurological involvement

Detection of anti-myeloperoxidase antibodies in the serum of patients with type 1 diabetes mellitus

Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels

Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.

Glucocorticoid excess and COVID-19 disease

Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells

Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease

IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells

Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis.

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs

Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation

Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.

Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome

The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 lymphocytes in patients with early rheumatoid arthritis

The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome.